Ameriprise’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $885K | Sell |
94,075
-175
| -0.2% | -$1.65K | ﹤0.01% | 3293 |
|
|
2025
Q1 | $511K | Buy |
94,250
+42,212
| +81% | +$229K | ﹤0.01% | 3446 |
|
|
2024
Q4 | $388K | Buy |
52,038
+27,151
| +109% | +$202K | ﹤0.01% | 3591 |
|
|
2024
Q3 | $199K | Sell |
24,887
-897,032
| -97% | -$7.17M | ﹤0.01% | 3746 |
|
|
2024
Q2 | $8.02M | Buy |
921,919
+248,571
| +37% | +$2.16M | ﹤0.01% | 1943 |
|
|
2024
Q1 | $13.9M | Sell |
673,348
-862,777
| -56% | -$17.8M | ﹤0.01% | 1523 |
|
|
2023
Q4 | $35.5M | Buy |
1,536,125
+1,525,776
| +14,743% | +$35.3M | 0.01% | 939 |
|
|
2023
Q3 | $82.7K | Buy |
+10,349
| New | +$82.7K | ﹤0.01% | 3810 |
|
|
2022
Q3 | – | Sell |
-63,986
| Closed | -$504K | – | 3976 |
|
|
2022
Q2 | $504K | Buy |
63,986
+3,050
| +5% | +$24K | ﹤0.01% | 3383 |
|
|
2022
Q1 | $740K | Sell |
60,936
-300
| -0.5% | -$3.64K | ﹤0.01% | 3325 |
|
|
2021
Q4 | $750K | Buy |
61,236
+37,236
| +155% | +$456K | ﹤0.01% | 3377 |
|
|
2021
Q3 | $250K | Buy |
24,000
+8,600
| +56% | +$89.6K | ﹤0.01% | 3644 |
|
|
2021
Q2 | $138K | Buy |
+15,400
| New | +$138K | ﹤0.01% | 3788 |
|